News
Staphyt and GenoScreen join forces to offer integrated solutions in genomics, regulatory studies and field trials
21/01/2026 — Staphyt, a leading contract research organization (CRO) and regulatory affairs consultant for agricultural experimentation and risk assessment, and GenoScreen, a pioneer and specialist in genomic and bioinformatics solutions, are pleased to announce the signing of a strategic collaboration agreement.
New EFSA Guidance for microorganisms (2025) : What changes and how GenoScreen help you stay fully compliant
Following its agenda to regulate the Food and Feed industry with up-to-date regulatory texts, the EFSA significantly raised the technical expectations for the characterisation and risk assessment of microorganisms used in food and feed. As of November 4th, 2025, dossiers that rely on outdated genomic analysis, incomplete resistance screening or...
How to scientifically and regulatory validate a probiotic or postbiotic Strain (EFSA, FDA)?
What are the requirements for marketing a probiotic or postbiotic strain? Developing supplements or functional foods containing a biotic strain involves much more than simply demonstrating their effectiveness. This process is essential for obtaining regulatory approvals from authorities such as the European Food Safety Authority (EFSA) and the U.S. Food and...
Focus
Predicting Tuberculosis Antibiotic Resistance
Deeplex® Myc-TB is an all-in-one test enabling species-level identification of mycobacteria, genotyping, and antibiotic resistance prediction for Mycobacterium tuberculosis complex strains.